explore -WSS

explore

author：entertainment 2025-09-06 03:17:21 - browse：711

Chris O'Meara/AP

Johnson & Johnson faces a consequential new class action lawsuit — not in its role as a manufacturer of drugs, but as an employer and purchaser of prescription drugs for its workers.

Ann Lewandowski, a health care policy and advocacy director at J&J, sued her company on Monday for allegedly overpaying its pharmacy benefit manager for its employees’ medicines, citing previous STAT reporting to support some of the allegations. Those overpayments, the lawsuit alleges, ultimately come out of workers’ paychecks in the form of high health insurance premiums, higher out-of-pocket drug costs, and stunted wage growth.

In one example, J&J allegedly paid its PBM more than $10,000 for a single 90-day prescription of teriflunomide, a generic medicine for multiple sclerosis, when that same 90-day prescription could be purchased for as little as $30 elsewhere without insurance, according to the lawsuit.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： FTC sues over Novant Health acquisition of two N.C. hospitals

WSS

STAT wants to know your pick for a great summer read or listen

Pancreatic cancer early detection could be helped by AI

The Affordable Care Act has saved billions in health care costs

Vertex non

The wait for US passports is creating travel purgatory and snarling summer plans

Medicare Advantage insurers face 0.2% cut to 2025 payments

Wikipedia

explore

knowledge

Medical records are filled with copy

Syphilis numbers in the United States reach record heights

Trump demands the U.S. pay no more for drugs than other countries … again

Dexcom's push to bring CGM to type 2 diabetes patients

Activists slam private health insurers over coverage restrictions

Dexcom's push to bring CGM to type 2 diabetes patients

Dobbs anniversary: the lost opportunity of abortion as health care

Zyn nicotine pouches become unlikely player in latest culture war

How one medical school became remarkably diverse

Readout Newsletter: The latest on Novavax, Merck, Bluebird

focus

Undocumented workers face uncertainty as immigration law takes effect in Florida

Correcting Robert F. Kennedy Jr.'s vaccine 'facts'

Top Ukrainian generals say counteroffensive is 'going to plan' as losses mount

Readout Newsletter: The latest on Novavax, Merck, Bluebird

Grandmother of French teen shot dead by police officer pleads with rioters to stop the violence

Vertex non

Wikipedia

explore

entertainment

explore